Evidence map›Paper›PMID 41683526›Full record

ArticleMolecules (Basel, Switzerland)2026

Selective Cytotoxic and Antiproliferative Effects of Extracts from Four Mexican Medicinal Plants in Human Cancer and Non-Cancerous Cell Lines.

Joel Daniel Castañeda-Espinoza, Yessica Arisbeth Alvarez Soto, Silvia Marquina-Bahena, Guillermo Antonio Madariaga Sosa, Karina Lizbeth Zagal Laguna, Araceli Guerrero-Alonso, Enrique Salas-Vidal, Janette Furuzawa-Carballeda, Juan M Uriostegui-Velarde, Carlos Mojica Cardoso and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Extracts fromFrontiers in pharmacology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Joel Daniel Castañeda-EspinozaCentro de Desarrollo de Productos Bióticos, Instituto Politécnico Nacional, Carretera Yautepec-Jojutla s/n-km. 85, San Isidro, Yautepec 62739, Morelos, Mexico.ORCID 0000-0002-3897-7816
Yessica Arisbeth Alvarez SotoFacultad de Farmacia, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, Mexico.
Silvia Marquina-BahenaCentro de Investigaciones Químicas-IICBA, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, Mexico.ORCID 0000-0001-5082-9798
Guillermo Antonio Madariaga SosaFacultad de Farmacia, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, Mexico.
Karina Lizbeth Zagal LagunaFacultad de Farmacia, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, Mexico.
Araceli Guerrero-AlonsoCentro de Investigaciones Químicas-IICBA, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, Mexico.
Enrique Salas-VidalDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de Mexico, Cuernavaca 62209, Morelos, Mexico.ORCID 0000-0001-7854-0478
Janette Furuzawa-CarballedaDepartamento de Cirugía Experimental, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de Mexico 14080, Mexico.ORCID 0000-0001-5804-7221
Juan M Uriostegui-VelardeFacultad de Ciencias Biológicas, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, Mexico.
Carlos Mojica CardosoLaboratorio de Patología, Hospital del Niño Morelense, Av. de la Salud #1 Col. Benito Juárez, Emiliano Zapata 62765, Morelos, Mexico.
Abraham Noé Anzurez JiménezLaboratorio de Patología, Hospital del Niño Morelense, Av. de la Salud #1 Col. Benito Juárez, Emiliano Zapata 62765, Morelos, Mexico.
Estela Carranza ValenciaInstituto Politécnico Nacional, Av. Luis Enrique Erro S/N, Unidad Profesional Adolfo López Mateos, Zacatenco, Alcaldía Gustavo A. Madero, Ciudad de Mexico 07738, Mexico.
Erick Ayala CalvilloFacultad de Farmacia, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, Mexico.
Jessica Nayelli Sánchez-CarranzaFacultad de Farmacia, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, Mexico.ORCID 0000-0002-6555-6267

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Agents, PhytogenicPlant ExtractsPlants, MedicinalCell CycleCell Line, TumorCell ProliferationDrug Screening Assays, AntitumorFemaleFibroblastsHumansMexicoAntineoplastic Agents, PhytogenicPlant Extractsantiproliferative activitycervical cancerCochlospermum vitifoliumEryngium heterophyllumHeLahuman uterine fibroblasts (HUF)IC50Mexican medicinal plantsPiper auritumselective cytotoxicityselectivity indexSemialarium mexicanumSiHa

Identifiers

PMID41683526
PMCPMC12899643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.